The Drug Delivery to the Lungs (DDL) Conference provides an annual forum for scientists, academics, clinicians, regulatory and industry specialists involved in developing medicines for inhalation.
Fluidda is actively involved in clinical trial management for the development of better medicines to treat diseases of the lung using Functional Respiratory Imaging technology (FRI) and is an expert in conducting deposition studies to support dose finding or optimize powder characteristics.
Fluidda will be present at the conference. If you would like to make an appointment to further discuss the opportunity to use Fluidda’s expertise, technique and network in your upcoming clinical trials, please send us a message at [email protected].
More information on DDL can be found at https://aerosol-soc.com/events/ddl2019/
Categorised in: Conferences / December 6, 2019 11:38 am /Tags: Conference, DDL